Abstract

BackgroundErythema nodosum leprosum (ENL) is a common immune-mediated complication of lepromatous (LL) and borderline lepromatous (BL) leprosy. Most patients experience chronic or multiple acute ENL over many years during an economically active period of their lives. Understanding the economic burden of ENL is essential to provide effective patient support, yet this area has not been investigated.MethodsNinety-one patients with LL or BL leprosy attending a leprosy hospital in Purulia district of West Bengal, India, were interviewed using a structured questionnaire. Cases (n = 53) were identified as those who had one or more episodes of ENL within the last 3 years. Controls (n = 38) had LL or BL leprosy but no history of ENL. Data were collected on household income, direct and indirect costs, and coping strategies.FindingsThe total household cost was Rs 1543 per month or 27.9% (IQR 13.2-52.6) of monthly household income for cases, and Rs 237 per month or 4.9% (IQR 1.7-13.4) of monthly household income for controls. Indirect costs accounted for 65% of total household costs for cases. Direct costs accounted for the remaining 35% of household costs, and resulted almost entirely from treatment-seeking in the private sector. Total household costs exceeded 40% of household income for 37.7% of cases (n = 20) and 2.6% of controls (n = 1) [1 USD = 59 INR].InterpretationHouseholds affected by ENL face significant economic burden and are at risk of being pushed further into poverty. Health policy should acknowledge the importance of private sector provision and the significant contribution to total household costs of lost productivity (indirect cost). Further work is needed to explore this area and identify solutions.

Highlights

  • Leprosy is a disease of poverty, affecting poor and marginalised communities in tropical countries throughout the world.[1]

  • We show that having a family member affected by Erythema nodosum leprosum (ENL) places considerable financial burden on households in rural India

  • We show that having a family member with ENL places considerable financial strain on households in rural India

Read more

Summary

Introduction

Leprosy is a disease of poverty, affecting poor and marginalised communities in tropical countries throughout the world.[1]. Leprosy reactions occur in up to 50% of patients with multibacillary leprosy and cause nerve damage and disability.[2,3] Two types of reaction can occur: type 1 reaction (T1R) and type 2 reaction (T2R) or erythema nodosum leprosum (ENL). Erythema nodosum leprosum (ENL) is an immune-mediated complication affecting patients with LL and BL leprosy. The physical impact of ENL is significant—patients suffer repeated episodes of ill health over many years and many develop impaired organ function, deformity and disability.[5] Patients need prolonged courses of high-dose steroids or thalidomide to control inflammation, and this can cause adverse effects including steroid dependency.[6]. Erythema nodosum leprosum (ENL) is a common immune-mediated complication of lepromatous (LL) and borderline lepromatous (BL) leprosy. Understanding the economic burden of ENL is essential to provide effective patient support, yet this area has not been investigated

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call